Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.

Chakravarty K, McDonald H, Pullar T, Taggart A, Chalmers R, Oliver S, Mooney J, Somerville M, Bosworth A, Kennedy T; British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group; British Association of Dermatologists (BAD).

Rheumatology (Oxford). 2008 Jun;47(6):924-5. Epub 2006 Aug 28. No abstract available.

PMID:
16940305
[PubMed - indexed for MEDLINE]
Free Article
2.

Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists.

Bhalla AK, Samaranayaka M.

Rheumatology (Oxford). 2008 Oct;47(10):1591; author reply 1591. doi: 10.1093/rheumatology/ken322. Epub 2008 Aug 1. No abstract available.

PMID:
18676499
[PubMed - indexed for MEDLINE]
Free Article
3.

Rational disease-modifying anti-rheumatic drug (DMARD) therapy: is it possible?

Furst DE.

Br J Rheumatol. 1996 Aug;35(8):707-8. No abstract available.

PMID:
8761179
[PubMed - indexed for MEDLINE]
Free Article
4.

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.

Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, Kiely P, Bukhari M, Abernethy R, Bosworth A, Ostor A, Gadsby K, McKenna F, Finney D, Dixey J, Deighton C; Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee; BHPR.

Rheumatology (Oxford). 2010 Nov;49(11):2217-9. doi: 10.1093/rheumatology/keq249a. Epub 2010 Sep 12. No abstract available.

PMID:
20837498
[PubMed - indexed for MEDLINE]
Free Article
5.

An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.

van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR.

Clin Ther. 2009 Aug;31(8):1737-46. doi: 10.1016/j.clinthera.2009.08.009. Review.

PMID:
19808132
[PubMed - indexed for MEDLINE]
6.

Shared care between hospital and general practice: an audit of disease-modifying drug monitoring in rheumatoid arthritis.

Helliwell PS, O'Hara M.

Br J Rheumatol. 1995 Jul;34(7):673-6.

PMID:
7670788
[PubMed - indexed for MEDLINE]
7.

Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?

Rajakulendran S, Gadsby K, Deighton C.

Musculoskeletal Care. 2008 Dec;6(4):233-45. doi: 10.1002/msc.135.

PMID:
18702106
[PubMed - indexed for MEDLINE]
8.

[Pharmacotherapy of rheumatic diseases in the aged].

Kary S, Buttgereit F, Burmester GR.

Internist (Berl). 2003 Aug;44(8):951-8. Review. German.

PMID:
14671809
[PubMed - indexed for MEDLINE]
9.

Drug therapy for patients with rheumatoid arthritis.

Arthur V.

Br J Nurs. 1995 Jun 8-21;4(11):616-21. Review.

PMID:
7626934
[PubMed - indexed for MEDLINE]
10.

Efficacy and toxicity of old and new disease modifying antirheumatic drugs.

Tugwell P, Welch V, Suarez-Almazor M, Shea B, Wells G.

Ann Rheum Dis. 2000 Nov;59 Suppl 1:i32-5. Review. No abstract available.

PMID:
11053083
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.

Meyer O, de Bandt M, Berthelot JM, Cantagrel A, Combe B, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Saraux A, Wendling D, Guillemin F, Le Loët X; Working Group for Therapeutic Strategies for Rheumatoid Arthritis.

Joint Bone Spine. 2007 Jan;74(1):73-8. Epub 2006 Nov 29.

PMID:
17194614
[PubMed - indexed for MEDLINE]
12.

British Society for Rheumatology Biologics Register.

Silman A, Symmons D, Scott DG, Griffiths I.

Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii28-9.

PMID:
14532144
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Management of early rheumatoid arthritis.

Suresh E.

J Assoc Physicians India. 2007 May;55:355-62. Review.

PMID:
17844697
[PubMed - indexed for MEDLINE]
14.

Early intervention with disease-modifying therapy for rheumatoid arthritis: where do the delays occur?

Potter T, Mulherin D, Pugh M.

Rheumatology (Oxford). 2002 Aug;41(8):953-5; author reply 955. No abstract available.

PMID:
12154222
[PubMed - indexed for MEDLINE]
Free Article
15.

Combination therapy for early rheumatoid arthritis.

[No authors listed]

Drug Ther Bull. 2006 Nov;44(11):81-5. Review.

PMID:
17089920
[PubMed - indexed for MEDLINE]
16.

Rheumatology. Part 2: The role of medication.

Byrne J.

Prof Nurse. 1999 Feb;14(5):353-8. Review.

PMID:
10205553
[PubMed - indexed for MEDLINE]
17.

[Rheumatoid arthritis today].

Leuchten N, Aringer M.

Internist (Berl). 2008 Dec;49(12):1471-80; quiz 1481. doi: 10.1007/s00108-008-2228-3. German.

PMID:
18985308
[PubMed - indexed for MEDLINE]
18.

Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.

Proudman SM, Keen HI, Stamp LK, Lee AT, Goldblatt F, Ayres OC, Rischmueller M, James MJ, Hill CL, Caughey GE, Cleland LG.

Semin Arthritis Rheum. 2007 Oct;37(2):99-111. Epub 2007 Mar 27.

PMID:
17391739
[PubMed - indexed for MEDLINE]
19.

Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.

Chan G, Goh F, Hodgson T, Hsu E, Johnstone D, Ly J, Platt T, Rodrigues E, Tsai W, Hider P, Gray A, Highton J.

N Z Med J. 2008 May 23;121(1274):34-41.

PMID:
18535644
[PubMed - indexed for MEDLINE]
20.

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ.

Arthritis Rheum. 2008 Oct;58(10):2968-80. doi: 10.1002/art.23940.

PMID:
18821691
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk